SCOTT BASS heads the firm’s Global Life Sciences team, coordinating pharmaceutical, medical device, food and dietary supplement matters in the United States, Europe and Asia. He is ranked internationally among the top authorities on FDA-related enforcement and regulatory issues, and has led audits and investigations involving off-label promotion, pharmacovigilance, PDMA, GMP, and fraud and abuse issues, as well as DEA and FTC matters. Scott has also acted as an expert on an EU Commission panel, an advisor on new China drug and device legislation and as an advisor on an FDA dietary supplement website.
Scott has represented such companies as Bayer, Genentech, Colgate Palmolive, Allergan, Novartis, Cargill, Herbalife and Roche in a number of regulatory or enforcement matters. His experience includes:
Scott’s work defending and advising clients and governments has earned him a leading status in numerous industry publications. According to Chambers USA, “The ‘phenomenal’ Scott Bass leads the firm’s global life sciences group and is recognized for his strengths in the regulatory enforcement sphere, routinely handling investigations involving off-label promotion, fraud and abuse, and pharmacovigilance.” Clients say: “He is very available, very experienced and gives very wise advice.” Chambers previously reported that: he “wins plaudits for being ‘highly responsive to client needs,’” and has “a lot of depth in good manufacturing practices and international law.” He is recognized as one of The Best Lawyers in America in FDA Law (2013–2017 editions); is “regarded as one of the pre-eminent authorities on FDA enforcement” by Who’s Who Legal; was recommended in the “Healthcare: Life Sciences” category in The Legal 500 United States 2013 and 2017 and was named an “Outstanding Advisor” by the publication. Scott was the only Life Sciences lawyer with leading rankings in both the “Government Enforcement and Investigation” and “Regulatory” categories in PLC’s surveys of leading Life Sciences lawyers worldwide, since 2006.
Scott is featured again as a “Life Sciences Star” in the 2016 edition of LMG Life Sciences. He was inducted into the Hall of Fame for both his outstanding FDA and Government Enforcement work in the second edition of LMG Life Sciences2013. On several occasions, BTI Consulting, on the basis of a survey of Fortune 1000 companies, has named Scott as a member of the BTI Client Service All-Star Team for law firms (one of the top five U.S. lawyers recognized by BTI as “MVP: Truly Outstanding” in 2007). Sidley’s FDA practice also received a first-tier national ranking in the U.S. News – Best Lawyers® “Best Law Firms” 2014 rankings. Washingtonian magazine included Scott again on its 2015 list of Washington’s Best Lawyers as one of the region’s “best legal minds” in the area of Food & Drug Law. In addition, Scott is recognized in the 2016 edition of Who’s Who Legal: Life Sciences, and as a Local Litigation Star in Benchmark Litigation for 2017.
